Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Better Buy: Ocugen vs. Novavax

TheMotleyFool

0 0

The COVID-19 pandemic isn't over. A new variant of the virus, called omicron, is now making its way around the world. This new strain of the virus seems more contagious than the previous ones, but we still have a lot to learn about it. However, these recent developments highlight the importance of vaccines in the fight against COVID-19.

While companies such as Pfizer and Moderna currently dominate the coronavirus-vaccine market, there may be space for newcomers. Two biotechs looking to enter this market are Ocugen (NASDAQ: OCGN) and Novavax (NASDAQ: NVAX). But which of these two vaccine makers is the better buy right now? Let's look into these companies' businesses and decide.